David W Dorman Cvs Health Corp (CVS) insider trading activity

CVS Quotes by TradingView

David W Dorman is Director of CVS HEALTH Corp. Currently has a direct ownership of 109,875 shares of CVS, which is worth approximately $4.86 Million. The most recent transaction as insider was on May 11, 2022, when has been sold 51 shares (Common Stock) at a price of $97.99 per share, resulting in proceeds of $4,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
0% 3M change
0% 12M change
Total Value Held $4.86 Million

DAVID W DORMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 11 2022
BUY
Grant, award, or other acquisition
$4,997 $97.99 p/Share
51 Added 0.05%
109,875 Common Stock
Nov 17 2021
BUY
Grant, award, or other acquisition
$292,470 $92.73 p/Share
3,154 Added 2.79%
109,824 Common Stock
May 13 2021
BUY
Grant, award, or other acquisition
$292,417 $84.27 p/Share
3,470 Added 3.15%
106,670 Common Stock
Nov 18 2020
BUY
Grant, award, or other acquisition
$292,471 $66.35 p/Share
4,408 Added 3.03%
140,900 Common Stock
May 14 2020
BUY
Grant, award, or other acquisition
$292,483 $62.31 p/Share
4,694 Added 3.32%
136,492 Common Stock
Nov 20 2019
BUY
Grant, award, or other acquisition
$292,488 $74.92 p/Share
3,904 Added 2.88%
131,798 Common Stock
May 16 2019
BUY
Grant, award, or other acquisition
$292,462 $52.3 p/Share
5,592 Added 4.19%
127,894 Common Stock
Mar 08 2019
BUY
Open market or private purchase
$506,016 $52.71 p/Share
9,600 Added 7.28%
122,302 Common Stock
Nov 07 2018
BUY
Grant, award, or other acquisition
$284,990 $78.77 p/Share
3,618 Added 3.11%
112,702 Common Stock
Jun 04 2018
BUY
Grant, award, or other acquisition
$284,989 $64.1 p/Share
4,446 Added 3.92%
109,084 Common Stock
May 04 2018
BUY
Open market or private purchase
$1,511,946 $62.22 p/Share
24,300 Added 18.85%
104,638 Common Stock
Nov 08 2017
BUY
Grant, award, or other acquisition
$284,998 $68.99 p/Share
4,131 Added 4.89%
80,338 Common Stock
May 10 2017
BUY
Grant, award, or other acquisition
$284,990 $80.94 p/Share
3,521 Added 4.42%
76,207 Common Stock
Nov 02 2016
BUY
Grant, award, or other acquisition
$284,926 $83.95 p/Share
3,394 Added 4.46%
72,686 Common Stock
May 19 2016
BUY
Grant, award, or other acquisition
$284,982 $100.95 p/Share
2,823 Added 3.91%
69,292 Common Stock
Nov 04 2015
BUY
Grant, award, or other acquisition
$284,969 $99.57 p/Share
2,862 Added 4.13%
66,469 Common Stock
May 07 2015
BUY
Grant, award, or other acquisition
$284,964 $99.36 p/Share
2,868 Added 4.31%
63,607 Common Stock
Nov 05 2014
BUY
Grant, award, or other acquisition
$284,988 $87.5 p/Share
3,257 Added 5.09%
60,739 Common Stock
May 08 2014
BUY
Grant, award, or other acquisition
$284,930 $75.86 p/Share
3,756 Added 6.13%
57,482 Common Stock

Also insider at

PYPL
PayPal Holdings, Inc. Financial Services
Director
DELL
Dell Technologies Inc. Technology
Director
DWD

David W Dorman

Director
Woonsocket, RI

Track Institutional and Insider Activities on CVS

Follow CVS HEALTH Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

News

Receive news related to CVS HEALTH Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CVS